Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study

Bibliographic Details
Title:	Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
Authors:	Agrawal, Prashasti ^{a, b}, Offin, Michael ^{a, b}, Lai, Victoria ^{a, b, ∗}, Ginsberg, Michelle S. ^c, Adusumilli, Prasad S. ^d, Rusch, Valerie W. ^d, Sauter, Jennifer L. ^e, Ho, Teresa ^f, Wong, Phillip ^f, Zauderer, Marjorie G. ^{a, b, ∗}
Source:	In JTO Clinical and Research Reports January 2025 6(1)
Database:	ScienceDirect

More Details
ISSN:	26663643
DOI:	10.1016/j.jtocrr.2024.100756
Published in:	JTO Clinical and Research Reports
Language:	English